# EDGAR Filing Document

**Accession Number:** 0000725363
**File Stem:** 0001654954-26-004547
**Filing Date:** 2026-5
**Character Count:** 1833
**Document Hash:** 9a72e84c7e4895eca08e50f2804099a6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-004547.hdr.sgml**: 20260610

**ACCESSION NUMBER**: 0001654954-26-004547

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260507

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEL SCI CORP
- **CENTRAL INDEX KEY:** 0000725363
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 840916344
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD .
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182
- **BUSINESS PHONE:** 7035069460

**MAIL ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD.
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTERLEUKIN 2 INC
- **DATE OF NAME CHANGE:** 19880317

**CEL-SCI CORPORATION**

8229 Boone Blvd. #802

Vienna, Virginia 22182

(703) 506-9460

May 7, 2026

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re: CEL-SCI Corporation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form S-1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EC File No. 333-295168

CEL-SCI Corporation withdraws its request for the acceleration of the above referenced registration statement.

---

| | |
|:---|:---|
| Very Truly Yours, <br> **CEL-SCI CORPORATION** | Very Truly Yours, <br> **CEL-SCI CORPORATION** |
| By: | /s/ Geert Kersten |
|  | Geert Kersten |
|  | Chief Executive Officer |

---